Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028951 · ClinicalTrials.gov registry record · Phase 3
Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
A Phase 3 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00028951: Completed Phase 3 study, sponsored by Gynecologic Oncology Group.
NCT00028951 is a Phase 3 study that has completed, run by Gynecologic Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00028951, a Phase 3 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Fibrin sealant may decrease lymphedema following surgery to remove lymph nodes in the groin by helping to seal the lymphatic vessels. It is not yet known if fibrin sealant is effective in decreasing lymphedema following surgery to remove lymph nodes. PURPOSE: Randomized phase III trial to determine the effectiveness of fibrin sealant in reducing lymphedema following surgical removal of lymph nodes in patients who have cancer of the vulva.
Interventions
- DRUG fibrin sealant
- PROCEDURE surgical wound closure
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-01 |
| Phase | Phase 3 |
What the finished NCT00028951 record still lists
NCT00028951 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which fibrin sealant is the first listed.
NCT00028951 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00028951 about?
NCT00028951 is a clinical study titled "Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva". RATIONALE: Fibrin sealant may decrease lymphedema following surgery to remove lymph nodes in the groin by helping to seal the lymphatic vessels. It is not yet known if fibrin sealant is effective in decreasing lymphedema following surgery to remove lymph nodes. PURPOSE: Randomized phase III trial t...
What is the current status of trial NCT00028951?
This trial is currently completed. It is a Phase 3 study. The study started on 2003-01.
What interventions are being tested in trial NCT00028951?
The interventions under investigation include: fibrin sealant (DRUG), surgical wound closure (PROCEDURE).
Who is sponsoring clinical trial NCT00028951?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia